Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
In December 2019 the coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was reported for the first time in Wuhan, China [1], and it subsequently rapidly spread to the rest of the world. On 11th March 2020 COVID-19 was declared a pandemic by the...
Saved in:
Main Authors: | Piotr Zielecki, Magdalena Kaniewska, Mariusz Furmanek, Tomasz Bulski, Grażyna Rydzewska |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2020-09-01
|
Series: | Gastroenterology Review |
Online Access: | https://www.termedia.pl/Effective-treatment-of-severe-acute-pancreatitis-and-COVID-19-pneumonia-with-tocilizumab,41,41798,1,1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia
by: Ruth Alex, et al.
Published: (2022-01-01) -
Gastrointestinal symptoms in COVID-19
by: Konrad Lewandowski, et al.
Published: (2022-01-01) -
Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) – friend or foe?
by: Konrad Lewandowski, et al.
Published: (2021-11-01) -
Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients
by: Yong Wang, et al.
Published: (2022-01-01) -
Skin and gastrointestinal symptoms in COVID-19
by: Piotr Ciechanowicz, et al.
Published: (2020-12-01)